Biosynex Actions Port. EO -,10
- BID
0.926
- ASK
0.946
- 10,799 Units10,571 Units
- 07/21, 18:03:40 PM
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
26.61%
Market Cap
-
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-3.11 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 90.93 Bil. | 31.27 Bil. | 22.35 | -4.61 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 0.926 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 06:03:40 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 0.93 | 0.89 |
| PREV. DAY'S PRICE | 0.888 | (07/20) |
| CHANGE DAY BEFORE | +0.04 | 4.28 % |
| 52 WEEK HIGH / LOW | 1.51 (05/11) | 0.456 (12/03) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026 | 2027 | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -2.85 | -3.33 | -3.11 | - | - |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | - | - |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | - | - | - |
PRICE - BOOK RATIO | 0.72 | 0.22 | 0.34 | - | - |
PRICE - SALES RATIO | 0.96 | 0.18 | 0.12 | - | - |
PRICE - CASH FLOW RATIO | - | - | - | - | - |
Master Data
| WKN | A1H8G1 |
| ISIN | FR0011005933 |
| SYMBOL | 0DL |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | BIOSYNEX INH. EO-,10 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 2.30 % | 0.68 % | 6.47 % | 22.65 % | -26.61 % | -89.17 % | -95.11 % | 59.14 % |
| HIGH | 0.95 | 1.02 | 1.51 | 1.51 | 1.51 | 9.02 | 23.42 | 1.51 |
| LOW | 0.85 | 0.81 | 0.70 | 0.70 | 0.46 | 0.46 | 0.46 | 0.57 |
Dividende
pro Aktie
BIOSYNEX INH. EO-,10 does not deliver dividend information
Company profile
Biosynex SA engages in the provision of development, production, and distribution of Rapid Diagnostics Tests (RDTs) for pathologies. It operates through the Professional and Consumer segments. The Professional segment allows proper medical management of the patients. The Consumer segment permits the general public to self-monitor. The company was founded by Larry Abensur, Thomas Lamy, and Thierry Paper on March 15, 2005 and is headquartered in Illkirch-Graffenstaden, France.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.